Dr Anna Dorothea Gorki

Anna Dorothea Gorki, PhD is an immunologist and experienced biotech executive, currently serving as Chief Scientific Officer (CSO) at YGION Biomedical, where she leads the development of precision medicine strategies for cancer vaccines. Previously, she was CSO at the start-up G.ST Antivirals, developing antiviral therapies for respiratory infections leading the preclinical team up to clinical phase II. Dr. Gorki completed her PhD and postdoc in immunology at the Medical University of Vienna, CeMM Research Center for Molecular Medicine and Weizmann Institute of Science, authoring high-impact publications in top-tier journals such as "Cell". Her work has earned multiple distinctions, including the Austrian Science Ministry’s Award of Excellence and the State Prize of Austria."